Fig. 7From: Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment(A) ALP activity and (B) calcium contents of MC3T3-E1 cells treated with C.M., O.M., NDs (100 μg/mL), and Alen-NDs (25, 50, and 100 μg/mL) after 3, 7, and 10 days. A bar beneath the *symbol indicates statistical significance (**p < 0.01) across all 5 experimental groups at each time pointBack to article page